1 North Wealth Services’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

1 North Wealth Services’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.47K	Hold	85	–	–	﹤0.01%	235
2025 Q4	$2.23K	Hold	85	–	–	﹤0.01%	246
2025 Q3	$2.01K	Hold	85	–	–	﹤0.01%	231
2025 Q2	$1.74K	Hold	85	–	–	﹤0.01%	239
2025 Q1	$1.74K	Buy	+85	New	+$1.9K	﹤0.01%	237

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

1 North Wealth Services's IDNA Position: Q1 2026 in Review

1 North Wealth Services held its iShares Genomics Immunology and Healthcare ETF (IDNA) position steady in Q1 2026 at 85 shares worth $2.47K. The position accounts for ﹤0.01% of the portfolio, ranked #235.

1 North Wealth Services first reported a position in IDNA in Q1 2025 and has held it in 5 quarters since. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

1 North Wealth Services held 85 shares of iShares Genomics Immunology and Healthcare ETF worth $2.47K as of Q1 2026.
1 North Wealth Services left its iShares Genomics Immunology and Healthcare ETF share count unchanged in Q1 2026.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of 1 North Wealth Services's portfolio in Q1 2026, its #235 holding.
1 North Wealth Services first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2025 and has held it in 5 quarters since.
60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on 1 North Wealth Services's 13F filing for Q1 2026, filed 4 May 2026.